Literature DB >> 35705789

The subjective minimal important change for the Six Spot Step Test in people with multiple sclerosis - The Danish MS Hospitals Rehabilitation study.

Uwe M Pommerich1,2, John Brincks3, Anders Guldhammer Skjerbæk4, Ulrik Dalgas5.   

Abstract

INTRODUCTION: The Six Spot Step Test has shown good psychometric properties in terms of validity and reliability in people with multiple sclerosis. Yet, the responsiveness and minimal important change are unknown. The objective was to investigate the responsiveness of the Six Spot Step Test against the perceived change of walking limitations and establish estimates for the minimal important change in people with multiple sclerosis.
METHODS: The Six Spot Step Test was performed before and after four weeks of specialised multidisciplinary inpatient rehabilitation by 142 adults with mild to severe multiple sclerosis. Responsiveness was determined based on anchor- and distribution-based methods, using the Multiple Sclerosis Walking Scale-12 as external criterion. In a supplementary analysis, the Six-Minute Walking Test was used as an external criterion.
RESULTS: The correlation between the baseline (r = 0.56, p < 0.01) and discharge (r = 0.55, p < 0.01) Multiple Sclerosis Walking Scale-12 and Six Spot Step Test scores were acceptable. Furthermore, the change scores were weakly associated (r = 0.1, p = 0.27). This trend was similar for the Six-Minute Walking Test when used as anchor. The smallest detectable change was estimated to 1.7 seconds. An improvement in the Six Spot Step Test exceeding 2.1 (95% CI - 0.9 to 5.0) sec and 4.9 (95% CI 1.2-8.6) sec may be considered clinically important on a group level based on the Multiple Sclerosis Walking Scale-12 and the Six-Minute Walking Test, respectively.
CONCLUSION: In a sample of mild to severely disabled people with multiple sclerosis, the Six Spot Step Test showed fair responsiveness against a subjective and objective criterion, indicating a minimal important change between ≥ 2.1 and ≥ 4.9 seconds, respectively. However, a weak association between the change in the Six Spot Step Test and the subjective and objective external criterion calls for cautious interpretation. Hence, the results should be further verified against a valid external criterion.
© 2022. The Author(s) under exclusive licence to Belgian Neurological Society.

Entities:  

Keywords:  Multiple sclerosis; Patient-reported outcome; Responsiveness; Six Spot Step Test; Walking

Mesh:

Year:  2022        PMID: 35705789     DOI: 10.1007/s13760-022-01991-4

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.471


  31 in total

1.  The six-spot-step test - a new method for monitoring walking ability in patients with chronic inflammatory polyneuropathy.

Authors:  Melissa Kreutzfeldt; Henrik B Jensen; Mads Ravnborg; Lars H Markvardsen; Henning Andersen; Søren H Sindrup
Journal:  J Peripher Nerv Syst       Date:  2017-06       Impact factor: 3.494

2.  How much does balance and muscle strength impact walking in persons with multiple sclerosis? - A cross-sectional study.

Authors:  Jacob Callesen; Ulrik Dalgas; John Brincks; Davide Cattaneo
Journal:  Mult Scler Relat Disord       Date:  2019-01-24       Impact factor: 4.339

3.  Perceptions on the value of bodily functions in multiple sclerosis.

Authors:  C Heesen; R Haase; S Melzig; J Poettgen; M Berghoff; F Paul; U Zettl; M Marziniak; K Angstwurm; R Kern; T Ziemssen; J P Stellmann
Journal:  Acta Neurol Scand       Date:  2017-12-03       Impact factor: 3.209

4.  Further validation of the Six-Spot Step Test as a measure of ambulation in multiple sclerosis.

Authors:  Brian M Sandroff; Robert W Motl; Jacob J Sosnoff; John H Pula
Journal:  Gait Posture       Date:  2014-10-23       Impact factor: 2.840

5.  The impact of dynamic balance measures on walking performance in multiple sclerosis.

Authors:  Nora E Fritz; Rhul Evans R Marasigan; Peter A Calabresi; Scott D Newsome; Kathleen M Zackowski
Journal:  Neurorehabil Neural Repair       Date:  2014-05-01       Impact factor: 3.919

6.  Utility of the Six-Spot Step Test as a Measure of Walking Performance in Ambulatory Individuals With Multiple Sclerosis.

Authors:  Nora E Fritz; Allen Jiang; Jennifer Keller; Kathleen M Zackowski
Journal:  Arch Phys Med Rehabil       Date:  2015-11-11       Impact factor: 3.966

7.  A study of the discriminative properties of the Six-Spot Step Test in people with Parkinson's disease at risk of falling.

Authors:  John Brincks; Julie Brøbech Jørgensen; Iben Engelbrecht Giese; Marie Louise Palle; Jacob Callesen; Erik Johnsen; Erhard Trillingsgaard Næss-Schmidt; Ulrik Dalgas
Journal:  NeuroRehabilitation       Date:  2019       Impact factor: 2.138

8.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

9.  A study of the validity of the Six-Spot Step Test in ambulatory people with Parkinson's disease.

Authors:  John Brincks; Jacob Callesen; Erik Johnsen; Ulrik Dalgas
Journal:  Clin Rehabil       Date:  2019-02-25       Impact factor: 3.477

10.  Profiling walking dysfunction in multiple sclerosis: characterisation, classification and progression over time.

Authors:  Linard Filli; Tabea Sutter; Christopher S Easthope; Tim Killeen; Christian Meyer; Katja Reuter; Lilla Lörincz; Marc Bolliger; Michael Weller; Armin Curt; Dominik Straumann; Michael Linnebank; Björn Zörner
Journal:  Sci Rep       Date:  2018-03-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.